Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNT
1101
DELISTED
Verint Systems
VRNT
| $12.5M | 0.02% |
585,606
+21,821
| +4% | +$440K |
|
1102
Houlihan Lokey
HLI
$9.01B
| $12.5M | 0.02% |
318,769
+1,631
| +0.5% | +$59.6K |
|
|
SASR
1103
DELISTED
Sandy Spring Bancorp Inc
SASR
| $12.5M | 0.02% |
300,482
+95,920
| +47% | +$3.77M |
|
1104
Sanofi
SNY
$109B
| $12.4M | 0.02% |
250,000
-50,000
| -17% | -$2.42M |
|
1105
Itron
ITRI
$4.32B
| $12.4M | 0.02% |
160,635
+93,353
| +139% | +$6.77M |
|
1106
First Bancorp
FBP
$4.31B
| $12.4M | 0.02% |
2,426,262
-2,066,004
| -46% | -$11.8M |
|
1107
Republic Services
RSG
$68.3B
| $12.4M | 0.02% |
187,977
+29,967
| +19% | +$1.95M |
|
|
COUP
1108
DELISTED
Coupa Software Incorporated
COUP
| $12.4M | 0.02% |
397,525
+287,565
| +262% | +$8.77M |
|
|
FRC
1109
DELISTED
First Republic Bank
FRC
| $12.4M | 0.02% |
118,305
-4,243
| -3% | -$421K |
|
1110
Hain Celestial
HAIN
$75.8M
| $12.3M | 0.02% |
299,410
+15,733
| +6% | +$650K |
|
1111
Grupo Aeroportuario Centro Norte
OMAB
$4.97B
| $12.3M | 0.02% |
277,409
+151,436
| +120% | +$7.36M |
|
1112
Collegium Pharmaceutical
COLL
$848M
| $12.3M | 0.02% |
1,172,797
+823,208
| +235% | +$9.08M |
|
1113
Booking.com
BKNG
$160B
| $12.3M | 0.02% |
167,700
+156,025
| +1,336% | +$11.8M |
|
1114
CALL
Mondelez International
MDLZ
$82.6B
| $12.3M | 0.02% |
302,000
-203,000
| -40% | -$8.62M |
|
1115
Criteo S.A.
CRTO
$837M
| $12.2M | 0.02% |
294,933
+24,115
| +9% | +$1.15M |
|
1116
Pinnacle Financial Partners Inc
PNFP
$15.3B
| $12.2M | 0.02% |
182,121
+17,665
| +11% | +$1.11M |
|
1117
Greif
GEF
$4.89B
| $12.2M | 0.02% |
207,924
+189,204
| +1,011% | +$10.8M |
|
1118
Tronox
TROX
$861M
| $12.2M | 0.02% |
576,224
-50,437
| -8% | -$1M |
|
|
AMRN
1119
Amarin Corp
AMRN
$292M
| $12.2M | 0.02% |
173,626
+77,228
| +80% | +$5.47M |
|
1120
Pentair
PNR
$10.1B
| $12.1M | 0.02% |
266,049
+121,924
| +85% | +$5.24M |
|
|
EPZM
1121
DELISTED
Epizyme, Inc
EPZM
| $12.1M | 0.02% |
637,140
+97,056
| +18% | +$1.48M |
|
1122
Warrior Met Coal
HCC
$5.63B
| $12.1M | 0.02% |
+514,828
| New | +$11.8M |
|
1123
Patterson-UTI
PTEN
$4.52B
| $12.1M | 0.02% |
578,558
-3,005,914
| -84% | -$55.4M |
|
1124
CEMIG Preferred Shares
CIG
$5.58B
| $12.1M | 0.02% |
9,568,632
+7,540,073
| +372% | +$10.3M |
|
|
XENT
1125
DELISTED
Intersect ENT, Inc
XENT
| $12.1M | 0.02% |
387,313
-519,134
| -57% | -$15.4M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.